Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 29, 2020-- |!| Oelwein
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 29, 2020-- |!| Oelwein